A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo

Not yet recruitingOBSERVATIONAL

Enrollment

170

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions

Vitiligo

Interventions

DRUG

Ruxolitinib 1.5% Cream BID

ruxolitinib twice per day

All Listed Sponsors

lead

Peking University Third Hospital

OTHER

NCT07153666 - A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo | Biotech Hunter | Biotech Hunter